Investing
CapEx
Pfizer CapEx increased by 40.4% to $845.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 7.9%, from $917.00M to $845.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows relatively stable performance with a -0.8% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase signals growth investment or infrastructure modernization; a decrease might suggest cost-cutting or a transition to an asset-light model.
Detailed definition
Funds used by a company to acquire, upgrade, and maintain physical assets such as property, plants, buildings, technolog...
Peer comparison
Hardware-focused tech firms typically have higher CapEx relative to revenue than pure software companies due to manufacturing and supply chain needs.
Metric ID:
cf_capital_expendituresHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $540.00M | $624.00M | $993.00M | $643.00M | $751.00M | $841.00M | $1.00B | $1.14B | $914.00M | $810.00M | $1.04B | $704.00M | $637.00M | $651.00M | $917.00M | $564.00M | $618.00M | $602.00M | $845.00M |
| QoQ Change | — | +15.6% | +59.1% | -35.2% | +16.8% | +12.0% | +19.0% | +13.8% | -19.8% | -11.4% | +28.9% | -32.6% | -9.5% | +2.2% | +40.9% | -38.5% | +9.6% | -2.6% | +40.4% |
| YoY Change | — | — | — | — | +39.1% | +34.8% | +0.8% | +77.1% | +21.7% | -3.7% | +4.3% | -38.2% | -30.3% | -19.6% | -12.2% | -19.9% | -3.0% | -7.5% | -7.9% |
Range$540.00M – $1.14B
CAGR+10.5%
Avg YoY Growth+2.4%
Median YoY Growth-3.7%
CapEx at Other Companies
Frequently Asked Questions
- What is Pfizer's capex?
- Pfizer (PFE) reported capex of $845.00M in Q4 2025.
- How has Pfizer's capex changed year-over-year?
- Pfizer's capex decreased by 7.9% year-over-year, from $917.00M to $845.00M.
- What is the long-term trend for Pfizer's capex?
- Over 4 years (2021 to 2025), Pfizer's capex has grown at a -0.8% compound annual growth rate (CAGR), from $2.71B to $2.63B.
- What does capex mean?
- The money spent on long-term physical assets like machinery, data centers, and office buildings.